Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026)
Elutia's (ELUT) quarterly Liabilities and Shareholders Equity came in at $55.2 million in Q1 2026, up 40.49% year-on-year from $39.3 million in Q1 2025, and down 11.45% quarter-over-quarter from $62.4 million in Q4 2025.
Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
Elutia has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $55.2 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $55.2 million, up 40.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.8 million (up 9.1% YoY), and the FY2025 annual result was $62.4 million, up 72.59% from the prior year.
- Liabilities and Shareholders Equity came in at $55.2 million for Q1 2026 at Elutia, down from $62.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $68.8 million in Q4 2022 to a low of $29.4 million in Q3 2025.
- The 5-year median for Liabilities and Shareholders Equity is $52.3 million (2023), against an average of $49.1 million.
- Across the five-year window, Liabilities and Shareholders Equity slumped 41.68% in 2024 and surged 72.59% in 2025, its largest moves.
- Elutia's Liabilities and Shareholders Equity stood at $68.8 million in 2022, then sank by 36.92% to $43.4 million in 2023, then slipped by 16.81% to $36.1 million in 2024, then soared by 72.59% to $62.4 million in 2025, then slipped by 11.45% to $55.2 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $55.2 million (Q1 2026), $62.4 million (Q4 2025), and $29.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Elutia | 45.15 Mn | 16.66 Mn | 1.80 Mn | 55.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.21 Mn |
| Dec 31, 2025 | 62.35 Mn |
| Sep 30, 2025 | 29.41 Mn |
| Jun 30, 2025 | 33.85 Mn |
| Mar 31, 2025 | 39.30 Mn |
| Dec 31, 2024 | 36.13 Mn |
| Sep 30, 2024 | 48.41 Mn |
| Jun 30, 2024 | 41.90 Mn |
| Mar 31, 2024 | 35.36 Mn |
| Dec 31, 2023 | 43.43 Mn |
| Sep 30, 2023 | 54.58 Mn |
| Jun 30, 2023 | 52.33 Mn |
| Mar 31, 2023 | 60.63 Mn |
| Dec 31, 2022 | 68.84 Mn |
| Sep 30, 2022 | 61.02 Mn |
| Jun 30, 2022 | 52.85 Mn |
| Mar 31, 2022 | 59.93 Mn |
| Dec 31, 2021 | 67.17 Mn |
| Sep 30, 2021 | 59.90 Mn |
| Jun 30, 2021 | 69.70 Mn |